Logo image of SOLV.BR

SOLVAC SA-REG (SOLV.BR) Stock Fundamental Analysis

Europe - EBR:SOLV - BE0003545531 - Common Stock

87.4 EUR
-1.4 (-1.58%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

4

Overall SOLV gets a fundamental rating of 4 out of 10. We evaluated SOLV against 66 industry peers in the Chemicals industry. SOLV has only an average score on both its financial health and profitability. SOLV is valued correctly, but it does not seem to be growing. SOLV also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

SOLV had positive earnings in the past year.
Of the past 5 years SOLV 4 years were profitable.
In multiple years SOLV reported negative operating cash flow during the last 5 years.
SOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

With a decent Return On Assets value of 4.55%, SOLV is doing good in the industry, outperforming 69.70% of the companies in the same industry.
SOLV has a Return On Equity of 5.00%. This is comparable to the rest of the industry: SOLV outperforms 54.55% of its industry peers.
SOLV has a Return On Invested Capital of 3.65%. This is comparable to the rest of the industry: SOLV outperforms 56.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SOLV is below the industry average of 7.02%.
The 3 year average ROIC (3.44%) for SOLV is below the current ROIC(3.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.55%
ROE 5%
ROIC 3.65%
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
SOLV.BR Yearly ROA, ROE, ROICSOLV.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With an excellent Profit Margin value of 95.09%, SOLV belongs to the best of the industry, outperforming 98.48% of the companies in the same industry.
SOLV's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 97.93%, SOLV belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of SOLV has grown nicely.
Industry RankSector Rank
OM 97.93%
PM (TTM) 95.09%
GM N/A
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
SOLV.BR Yearly Profit, Operating, Gross MarginsSOLV.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100 200 300 400

4

2. Health

2.1 Basic Checks

SOLV has about the same amout of shares outstanding than it did 1 year ago.
SOLV has about the same amout of shares outstanding than it did 5 years ago.
SOLV has a better debt/assets ratio than last year.
SOLV.BR Yearly Shares OutstandingSOLV.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SOLV.BR Yearly Total Debt VS Total AssetsSOLV.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

SOLV has an Altman-Z score of 5.55. This indicates that SOLV is financially healthy and has little risk of bankruptcy at the moment.
SOLV has a better Altman-Z score (5.55) than 92.42% of its industry peers.
SOLV has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
SOLV's Debt to Equity ratio of 0.06 is amongst the best of the industry. SOLV outperforms 89.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 5.55
ROIC/WACCN/A
WACCN/A
SOLV.BR Yearly LT Debt VS Equity VS FCFSOLV.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

SOLV has a Current Ratio of 0.69. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.69, SOLV is not doing good in the industry: 92.42% of the companies in the same industry are doing better.
A Quick Ratio of 0.69 indicates that SOLV may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.69, SOLV is doing worse than 84.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69
SOLV.BR Yearly Current Assets VS Current LiabilitesSOLV.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

SOLV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.04%.
The Earnings Per Share has been growing by 26.70% on average over the past years. This is a very strong growth
SOLV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.28%.
The Revenue has been growing by 24.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-38.04%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%28%
Revenue 1Y (TTM)-38.28%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%26.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SOLV.BR Yearly Revenue VS EstimatesSOLV.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
SOLV.BR Yearly EPS VS EstimatesSOLV.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

SOLV is valuated correctly with a Price/Earnings ratio of 14.84.
Based on the Price/Earnings ratio, SOLV is valued a bit cheaper than 75.76% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.69, SOLV is valued a bit cheaper.
With a Price/Forward Earnings ratio of 6.02, the valuation of SOLV can be described as very cheap.
Based on the Price/Forward Earnings ratio, SOLV is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
SOLV is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.84
Fwd PE 6.02
SOLV.BR Price Earnings VS Forward Price EarningsSOLV.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOLV.BR Per share dataSOLV.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.23
PEG (5Y)0.56
EPS Next 2YN/A
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

SOLV has a Yearly Dividend Yield of 4.52%, which is a nice return.
SOLV's Dividend Yield is rather good when compared to the industry average which is at 3.14. SOLV pays more dividend than 80.30% of the companies in the same industry.
SOLV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 4.52%

5.2 History

The dividend of SOLV has a limited annual growth rate of 1.34%.
Dividend Growth(5Y)1.34%
Div Incr Years0
Div Non Decr Years0
SOLV.BR Yearly Dividends per shareSOLV.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

The dividend of SOLV is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
SOLV.BR Yearly Income VS Free CF VS DividendSOLV.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

SOLVAC SA-REG

EBR:SOLV (10/20/2025, 7:00:00 PM)

87.4

-1.4 (-1.58%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-01 2025-08-01
Earnings (Next)11-06 2025-11-06
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.24%
Ins Owner ChangeN/A
Market Cap1.87B
Analysts42.22
Price Target143.97 (64.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Yearly Dividend5.8
Dividend Growth(5Y)1.34%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.84
Fwd PE 6.02
P/S 14.11
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)5.89
EY6.74%
EPS(NY)14.52
Fwd EY16.62%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.19
BVpS117.7
TBVpS117.7
PEG (NY)2.23
PEG (5Y)0.56
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 5%
ROCE 4.86%
ROIC 3.65%
ROICexc 3.74%
ROICexgc 3.74%
OM 97.93%
PM (TTM) 95.09%
GM N/A
FCFM N/A
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
ROICexc(3y)3.44%
ROICexc(5y)N/A
ROICexgc(3y)3.61%
ROICexgc(5y)N/A
ROCE(3y)4.58%
ROCE(5y)N/A
ROICexcg growth 3Y-27.07%
ROICexcg growth 5Y31.12%
ROICexc growth 3Y-24.14%
ROICexc growth 5Y34%
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z 5.55
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.04%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%28%
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.28%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%26.75%
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.39%
EBIT growth 3Y-28.15%
EBIT growth 5Y27.7%
EBIT Next Year44.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.44%
OCF growth 3YN/A
OCF growth 5YN/A